Credit card and PayPal contributions are working again. If you saw a "temporarily unavailable" message between October 10 and 14, we apologize - please try again. Thank you for supporting QuantumOnline.com.
Log in Register
    Lycia Therapeutics, Inc (LYCA)
    LYCA · NGS ·
    Last Price•••.••
    Current Yield•.••%
    Yield to Call•.••%
    Yield to Worst•.••%
    Register free Already a member? Log in
    Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LYCA and every other security on QuantumOnline.
    Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒
    🔒
    Price chart and 15 days of daily prices
    Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

    Security Profile

    Security Type
    Common Stock
    IPO
    10/23/2026 · $18.00/share
    Prospectus
    IPO prospectus »
    Links: Home Page Investor Relations News
    Business: Lycia Therapeutics, Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.

    Company Contact

    CEO
    Aetna Wun Trombley
    CFO
    Amy Bachrodt
    Headquarters
    400 East Jamie Court, Suite 200, South San Francisco, CA 94080
    Phone
    660-392-3367
    SEC EDGAR Filings
    View filings »
    QuantumOnline.com
    Copyright © 1997–2026 QuantumOnline.com. All rights reserved.